Edition:
United States

XOMA Corp (XOMA.O)

XOMA.O on Consolidated Issue listed on NASDAQ Global Market

17.23USD
22 May 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$17.23
Open
$16.90
Day's High
$17.38
Day's Low
$16.83
Volume
43,752
Avg. Vol
53,344
52-wk High
$25.99
52-wk Low
$11.02

About

XOMA Corporation is a development-stage biotechnology company. The Company focuses on the discovery and development of monoclonal antibody-based therapeutics. It has five products in its endocrine portfolio, two of which are developed as part of its XOMA Metabolism (XMet) platform. Its products include XOMA 358, XOMA 129, XOMA... (more)

Overall

Beta: 2.04
Market Cap(Mil.): $148.40
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

  XOMA.O Industry Sector
P/E (TTM): -- 93.91 35.38
EPS (TTM): -0.79 -- --
ROI: -11.89 7.62 11.72
ROE: -42.50 8.12 16.38

Earnings vs. Estimates